Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

NCT07385547 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: GL0034

Sponsor

Sun Pharmaceutical Industries Limited